Gratitude is good medicine for organ recipientsAugust 16, 2007After immunosuppressants, the best medicine for organ transplant patients might be gratitude. In a study of organ recipients, researchers from UC Davis and the Mississippi University for Women found that patients who keep "gratitude journals" score better on measures of mental health, general health and vitality than those who keep only routine notes about their days. "We found that increased feelings of gratitude can cause people's well-being and quality of life to improve," said Robert Emmons, a UC Davis professor who specializes in the study of gratitude.
Emmons conducted the study with Stefanie Greiner and Stephanie Ivie of the Mississippi University for Women. The study included four male and 12 female transplant recipients recruited via transplant e-mail groups and Web sites for transplant recipients. After completing initial questionnaires about their health and wellbeing, the subjects were randomly assigned to one of two groups. One group kept routine daily notes about medication side-effects, how they felt about life overall, how connected they were to others and how they felt about the upcoming day. Patients in the other group answered the same questions but were also asked to list five things or people they were grateful for each day and why they were grateful for them. They were asked to reflect on what they wrote as well. After 21 days, mental health and general wellbeing scores had risen for patients in the gratitude group but declined for those in the control group. Patients in the control group also reported a loss of vitality, while the grateful patients experienced no change. "It's likely that health and vitality scores declined in the control group because, unlike the experimental group, they did not benefit from the protective effect of gratitude," Emmons said. "Having a chronic medical condition puts one at risk for deteriorating mental health, and a reduction in one's sense of general health and vitality is an indicator of this. Gratitude may serve as a buffer against these risks." Emmons is a leading contributor to the positive psychology movement and the author of the recently released book "Thanks! How the New Science of Gratitude Can Make You Happier." He will also report the following research at the meeting: * "Good Things Come to Those Who Wait: Examining Trait Patience," in a "Personality, Culture and Identity" poster session at 11 a.m. on Friday, Aug. 17, in Moscone Halls ABC * "Gifted Self: Gratitude, Meaning Making, and Eudaimonic and Hedonic Well-Being," in a symposium titled "Search for Meaning - Emerging Research Spanning the Juncture of Social and Clinical Psychology" at 4 p.m. Saturday, Aug. 18, in Moscone Room 301 * "Patience as a Virtue: Religious and Psychological Perspectives," in a symposium titled "Positive Psychology and Spirituality - New Constructs, Measures and Populations" at noon on Sunday, Aug. 19, in Moscone Room 3001 UC Davis | |||||||||||||||||||||
|
Related Organ Transplant Current Events and Organ Transplant News Articles Montana State University researchers find gene that regulates mold's resistance to drugs Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold's resistance to drugs. What a Sleep Study Can Reveal About Fibromyalgia Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab. Newly discovered proteins in seminal fluid may affect odds of producing offspring Seminal fluid contains protein factors that, when transferred from a male to a female at mating, affect reproductive success. This is true of many different animals, from crickets to primates. UCSF marks a milestone with 500th transplant in heart and lung program UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung. Scientists confirm new virus responsible for deaths of transplant recipients in Australia In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Control and 454 Life Sciences link the discovery of a new arenavirus to the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia in April 2007. Scientists confirm new virus responsible for deaths of transplant recipients in Australia In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory (VIRDL) in Melbourne, Australia, the Centers for Disease Control and 454 Life Sciences link the discovery of a new arenavirus to the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia in April 2007. Mayo Clinic shows therapy effective for reducing lupus flares Mayo Clinic researchers have shown that an immunosuppressive drug used in organ transplant cases is effective in reducing flare-ups in patients with systemic lupus erythematosus (SLE). Inhaling Nitric Oxide Helps Liver Transplant Success Administering inhaled nitric oxide (NO) during surgery helps protect liver transplant patients from organ failure, according to a new study from researchers at the University of Alabama at Birmingham (UAB). Facial Transplantation May Be a Safer Option, Study Shows Researchers in Cincinnati and Louisville report that immunosuppressive risks associated with facial transplantation may be lower than thought, possibly making the procedure a safer option for people who have suffered severe facial injuries. Preclinical study suggests organ-transplant drug may aid in lupus fight A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found. More Organ Transplant Current Events and Organ Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||